Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $2.23 billion. The enterprise value is $1.92 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 42.21 million shares outstanding. The number of shares has increased by 16.10% in one year.
| Current Share Class | 42.21M |
| Shares Outstanding | 42.21M |
| Shares Change (YoY) | +16.10% |
| Shares Change (QoQ) | +7.66% |
| Owned by Insiders (%) | 7.96% |
| Owned by Institutions (%) | 88.93% |
| Float | 30.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.91 |
| Forward PS | 4.72 |
| PB Ratio | 6.52 |
| P/TBV Ratio | 6.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.22.
| Current Ratio | 5.26 |
| Quick Ratio | 4.89 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.65 |
Financial Efficiency
Return on equity (ROE) is -31.46% and return on invested capital (ROIC) is -16.77%.
| Return on Equity (ROE) | -31.46% |
| Return on Assets (ROA) | -14.06% |
| Return on Invested Capital (ROIC) | -16.77% |
| Return on Capital Employed (ROCE) | -24.22% |
| Revenue Per Employee | $914,926 |
| Profits Per Employee | -$284,808 |
| Employee Count | 323 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 25.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.15% in the last 52 weeks. The beta is 0.79, so TARS's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +101.15% |
| 50-Day Moving Average | 42.11 |
| 200-Day Moving Average | 46.89 |
| Relative Strength Index (RSI) | 76.67 |
| Average Volume (20 Days) | 696,355 |
Short Selling Information
The latest short interest is 8.14 million, so 19.28% of the outstanding shares have been sold short.
| Short Interest | 8.14M |
| Short Previous Month | 8.21M |
| Short % of Shares Out | 19.28% |
| Short % of Float | 26.67% |
| Short Ratio (days to cover) | 14.42 |
Income Statement
In the last 12 months, TARS had revenue of $295.52 million and -$91.99 million in losses. Loss per share was -$2.31.
| Revenue | 295.52M |
| Gross Profit | 216.90M |
| Operating Income | -98.05M |
| Pretax Income | -150.07M |
| Net Income | -91.99M |
| EBITDA | -96.42M |
| EBIT | -98.05M |
| Loss Per Share | -$2.31 |
Full Income StatementBalance Sheet
The company has $381.14 million in cash and $72.45 million in debt, giving a net cash position of $308.70 million or $7.31 per share.
| Cash & Cash Equivalents | 381.14M |
| Total Debt | 72.45M |
| Net Cash | 308.70M |
| Net Cash Per Share | $7.31 |
| Equity (Book Value) | 332.61M |
| Book Value Per Share | 7.88 |
| Working Capital | 384.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$80.87 million and capital expenditures -$1.95 million, giving a free cash flow of -$82.82 million.
| Operating Cash Flow | -80.87M |
| Capital Expenditures | -1.95M |
| Free Cash Flow | -82.82M |
| FCF Per Share | -$1.96 |
Full Cash Flow StatementMargins
Gross margin is 73.40%, with operating and profit margins of -33.18% and -31.13%.
| Gross Margin | 73.40% |
| Operating Margin | -33.18% |
| Pretax Margin | -31.13% |
| Profit Margin | -31.13% |
| EBITDA Margin | -32.63% |
| EBIT Margin | -33.18% |
| FCF Margin | n/a |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.10% |
| Shareholder Yield | -16.10% |
| Earnings Yield | -4.14% |
| FCF Yield | -3.72% |
Analyst Forecast
The average price target for TARS is $67.14, which is 27.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.14 |
| Price Target Difference | 27.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 40.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 5.81 and a Piotroski F-Score of 3.
| Altman Z-Score | 5.81 |
| Piotroski F-Score | 3 |